Internationale Zeitschrift für Arzneimittelentwicklung und -forschung

  • ISSN: 0975-9344
  • H-Index der Zeitschrift: 44
  • Zitierbewertung der Zeitschrift: 59.93
  • Journal-Impact-Faktor: 48.80
Indiziert in
  • Genamics JournalSeek
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • CiteFactor
  • Scimago
  • Verzeichnis der Indexierung von Forschungszeitschriften (DRJI)
  • OCLC – WorldCat
  • Publons
  • MIAR
  • Kommission für Universitätsstipendien
  • Euro-Pub
  • Google Scholar
  • SHERPA ROMEO
  • Geheime Suchmaschinenlabore
  • ResearchGate
Teile diese Seite

Abstrakt

Therapy Compliance in Hypertension: Indian Clinicians’ Viewpoint

Dave Nilanj S, Sharma Ramandeep T, Kulkarni Girish R and Sen Sankar

Context: Poor compliance to antihypertensive therapies has been linked to a variety of problems, including poor blood pressure control, rehospitalisation, and increased healthcare resource utilization.

Setting and Design: Considering this, a cross-sectional survey of health care physicians (HCPs) treating hypertension from government or private practice across the India was conducted.

Aims: The purpose of the survey was to capture clinician viewpoint on the therapy compliance in the management of hypertension.

Methods and Materials: This was a paper-based survey where all HCPs were asked to respond to survey questionnaire during a personal meeting with the study interviewer.

Results: Total 2746 clinicians from more than 150 cities across the India were involved in this survey. Approximately 69% of clinicians believed that more than 1/4th of patients are not controlled for their hypertension. Out of all responders, 93.5% expressed that non-compliance to the medicine is one of the major reasons for the uncontrolled hypertension. Around 94% of responders expressed that patient compliance program can improve the compliance to the medicine in hypertension management.

Conclusions: Indian clinicians feel that uncontrolled hypertension is still be a widely prevalent problem in spite of availability of effective antihypertensive drugs and non-compliance to the medication is one of the major modifiable risk factor for this.

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert